Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- Eastern Cooperative Oncology Group
- Study ID
- NCT00005847
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 120 Years
- Healthy Volunteers
- Not accepted
Interventions
- recombinant interferon alfa — BIOLOGICAL
- estramustine phosphate sodium — DRUG
- isotretinoin — DRUG
- mitoxantrone hydrochloride — DRUG
- paclitaxel — DRUG
- vinorelbine ditartrate — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. It is not yet known which treatment regimen is more effective in treating metastatic prostate cancer. PURPOSE: Randomized phase II trial to compare the effectiveness of combination chemotherapy with that of chemotherapy plus biological therapy in treating patients who have progressive or metastatic prostate cancer that has not responded to hormone therapy.
Key Dates
- Start date
- Apr 5, 2001
- Status verified
- Jun 2023
- Primary completion
- Jul 31, 2004
Study Design
- Allocation
- RANDOMIZED
- Primary purpose
- TREATMENT
Locations (19)
Find similar trials in Denver, CO
By condition
By specialty
By research site
Related Studies
- [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical ProstatectomyRecruiting · Proton Collaborative Group · Little Rock, Arkansas
- Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate CancerPHASE3 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona
- Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing ProstatectomyRecruiting · Massachusetts General Hospital · Boston, Massachusetts